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Summary Epithelial expression of HLA-DR determinants and CEA was studied by immunofluorescence in
tissue sections from 33 large bowel carcinomas of different histological grade and clinico-pathological stage;
flow cytometric DNA measurements were performed in 31 of the tumours. Well-differentiated carcinomas
showed a strikingly patchy staining, particularly for HLA-DR and all except one had a near-diploid DNA
content. The latter feature might reflect cancer development at an early stage where no distinctly aneuploid
DNA clone had as yet become a predominant subline. With decreasing degree of differentiation, the epithelial
antigen expression became more homogeneous for individual tumours and the proportion of distinctly
aneuploid DNA profiles increased. In the poorly differentiated group of carcinomas, epithelial staining was
quite uniform, both for HLA-DR determinants and for CEA, and those tumours studied for DNA content
were of the aneuploid variety. These observations are in agreement with the clonal proliferation theory of
tumour development proposed by Nowell in 1976.
The biological role of intraepithelial HLA-DR
molecules and CEA in human large bowel
carcinomas is poorly understood. CEA is expressed
more strongly in moderately differentiated
carcinomas than in those of good or poor
differentiation (Rognum et al., 1982a), whereas no
apparent relationship has been found between
HLA-DR expression and degree of tumour
differentiation (Daar et al., 1982). Thus, prognostic
evaluations cannot as yet be based on such
immunohistochemical studies. The DNA pattern of
the tumours, however, may be of significant
biological importance because predominantly
diploid carcinomas apparently show a slower and
more protracted clinical course than non-diploid
ones (Wolley et al., 1982).
The purpose of the present investigation of large
bowel carcinomas was to assess epithelial
expression of HLA-DR and CEA along with DNA
ploidy patterns in relation to variables of known
prognostic importance, such as histological grade
and clinico-pathological stage. We wanted to
examine if particular sets of biological features
might be compatible with selected developmental
stages of the malignant disease.
Materials and methods
Patients
Thirty-three large bowel carcinomas from 31
patients (mean age, 61 years; range, 28-90) were
studied immunohistochemically with regard to
expression of HLA-DR antigens and CEA. DNA
was measured in cell suspensions from 31 of the
tumours by flow cytometry (FCM). All tumours
were staged according to the extended Dukes'
scheme (Turnbull et al., 1967) and graded as well-,
moderately- or poorly-differentiated (Ashley, 1978).
Two sections from different parts of the tumours
were examined blindly by a pathologist. Only
tumours that received identical grade of
differentiation in both sections were selected to
ensure intra-specimen homogeneity of this variable.
Clinico-pathological features are given in Table I.
Immunohistochemistry
Tissue slices from each tumour were fixed in cold
96% ethanol and processed for paraffin embedding
as described previously (Brandtzaeg, 1974). Sections
cut at 6pm were dewaxed and subjected to paired
immunofluorescence staining at room temperature.
One section from each series was stained by a
trichrome routine method (HAS) containing
haematoxylin, azofloxin, and saffron (Stave &
Brandtzaeg, 1977).
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A murine monoclonal antibody to a nonpoly-
morphic human HLA-DR antigen (Beckton
Dickinson, Sunnyvale, Calif., USA) was applied
(1:20 for 20h) in an indirect 3-step immunofluo-
rescence method (Brandzaeg & Rognum, 1983)
including affinity purified biotinylated horse anti-
mouse IgG (0.05g IgGl-', 3h) and fluorescein
isothiocyanate (FITC)-labelled avidin (0.05gl-1,
30min), both purchased from Vector Laboratories
(Burlingame, Calif., USA). The horse reagent was
absorbed with insolubilized human serum to avoid
interspecies cross-reactions. Before application of
the monoclonal antibody, the sections were
incubated for 30min with a tetramethylrhodamine
isothiocyanate (TRITC)-labelled rabbit IgG anti-
CEA conjugate; its optical density (OD) ratio
(280nm/515nm) was 4.1 and its working
concentration 0.12g IgGl-1 (Rognum et al., 1980).
The red signal from this conjugate was enhanced by
combining the FITC-labelled avidin with a TRITC-
labelled swine anti-rabbit IgG (Brandtzaeg &
Rognum, 1983).
Observations were done in a Leitz Orthoplan
fluorescence microscope equipped with an Osram
HBO 200W lamp for excitation of rhodamine (red
emission), and with an XBO 150W lamp for
fluorescein (green emission). Narrowband excitation
and selective filtration of the fluorescence colours
were obtained with a Ploem-type epi-illuminator.
The epithelial staining for HLA-DR antigens and
CEA was scored semiquantitatively on arbitrary
scales from 0 to 3. HLA-DR+.cells showed usually
diffuse expression of such determinants throughout
the cytoplasm with peripheral intensification,
particularly apically in glandular structures. A score
of 0 was given for virtually no staining; 1 for faint
peripheral staining with extension into the
cytoplasm; and 3 for intense overall fluorescence.
Details about the scoring of CEA staining are given
elsewhere (Rognum et al., 1980). Both the tumour
and the adjacent transitional mucosa were
evaluated. The same investigator was responsible
for the fluorescence scoring throughout the study; a
blind test for reproducibility in a previous study did
not reveal any systematic error (Rognum et al.,
1980).
Flow cytometry
Five samples from each of 31 tumour specimens
were subjected to flow cytometric (FCM) DNA
measurements. Preparation and staining of the
single cell suspensions with ethidium bromide
(Gohde & Dittrich, 1971) were performed as
detailed elsewhere (Rognum et al., 1982b). The
FCM histograms were analysed by planimetry
(G6hde, 1973) and the percentage of pulses above
diploid level was calculated. Mouse spleen
lymphocytes were used as diploid (2c) reference.
Tumours showing peaks selectively within 25% of
this standard were assigned to the near diploid
(ND) group. (Vindel6v et al., 1983), where-as those
with one or more peaks above that level were
considered as being distinctly aneuploid (AN). The
criteria used for splitting the tumours into a ND
and an AN group have been described and
discussed in detail previously (Rognum et al.,
1982b).
Statistics
For comparison between groups the Mann-Whitney
U test was applied.
Results
Clinico-patholologicalfeatures (Table I)
Patients with carcinomas of homogenously poor
differentiation were significantly (P % 0.05) younger
(55+ 19 years) than those with well-differentiated
tumours (71+4 years). All homogenously well-
differentiated carcinomas were localized (Dukes'
stage A and B), whereas most poorly differentiated
ones were disseminated (Dukes' stage C and D).
Histological grade showed no apparent relation to
sex or tumour site. Six of the moderately
differentiated tumours were disseminated (Table I).
Well-differentiated tumours
All 6 homogenously well-differentiated tumours
showed a heterogeneous staining pattern for HLA-
DR antigens (Table I). In patient No. 3 the tumour
was predominantly negative, whereas the remaining
5 expressed a strikingly patchy or variegated
pattern (Figure 1). The staining for CEA was more
homogenous (Table I). Four of the 5 tumours
subjected to FCM showed a ND DNA profile.
Moderately differentiated tumours
The expression of HLA-DR antigens tended to be
more homogenous in the moderately-differentiated
tumours than in the well-differentiated ones; two
were uniformly negative, 14 showed one
predominant staining pattern (Figure 2), and only 4
showed a strikingly variegated pattern (Table I).
Intratumoural variation of the CEA staining was
present in 9/20 moderately-differentiated
carcinomas, but the variation was always small and
did not exceed one fluorescence score (Table I).
Fifteen of the moderately-differentiated tumours
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Table I Clinico-pathological information about the patients, epithelial
expression of HLA-DR antigens and CEA, and DNA ploidy within the
different histological grades and Dukes' stages
Patient Age/Sex HLA-DR
no. Score*
2
3
4
5
6
65M
69M
76F
74F
72F
70F
7 28F
8 55M
9 66M
10 52M
11 73M
12 78F
13 69M
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
28F
52M
54M
66F
63F
68M
67F
75M
69F
70M
47F
29M
39F
45F
54F
90F
68M
47F
0-3
0-3
0-1
0-3
0-3
0-1.5
0-3
0-2
0-1-2
0-1
1-1.5
1-1.5-2
0-0.5
0-1-1.5
0.5-2
0-0.5
1-2
1-2
1-2
0
0-3
0-3
0-0.5
0
0-1
0.5-1
0
2
3
0.5
2
0
2
CEA
Score*
1.5
1-1.5
1.5
1.5
2
1.5-2
2
2
1.5
1.5-2
1.5
1.5-2
1.5-2
1.5-2
1-2
2
1.5-2
1-2
1.5-2
2
2
3
3
2
1.5-2
2
2
1
1
1.5
0
2
1
DNA Dukes'
ploidy stage Tumour site
AN
ND
ND
ND
ND
AN
AN
AN
AN
AN
AN
AN
AN
AN
ND
ND
ND
ND
AN
AN
AN
AN
AN
,AN
ND
AN
AN
AN
AN
AN
A
A
A
A
B
B
A
A
B
B
B
B
B
B
B
B
B
B
B
B
C
C
C
C
D
D
B
B
C
C
C
D
D
Sigmoid flexure
Sigmoid flexure
Rectum
Ascending colon
Coecum
Rectum
Transverse colon
Coecum
Sigmoid flexure
Descending colon
Rectum
Sigmoid flexure
Ascending colon
Rectum
Coecum
Ascending colon
Rectum
Rectum
Rectum
Rectum
Sigmoid flexure
Ascending colon
Rectum
Rectum
Transverse colon
Rectum
Rectum
Ascending colon
Coecum
Sigmoid flexure
Sigmoid flexure
Sigmoid flexure
Ascending colon
*The fluorescence score of th
indicated by bold face.
Poorly differentiated tumours
All of the 7 poorly-differentiated carcinomas
showed a homogenous staining pattern, both for
HLA-DR and CEA (Figures 3 and 4, Table I).
Two cases were completely negative for HLA-DR
antigens (Figure 3) and one for CEA (Table I). All
tumours subjected to FCM DNA quantitation in
this group showed an AN DNA profile.
Combined evaluation of HLA-DR and CEA
expression in relation to tumour aggressiveness
Most (87%) of the localized carcinomas (Dukes'
stages A and B) showed heterogeneous expression
of one or both epithelial markers (Table II).
e predominating staining pattern is
Table II Localized and disseminated tumours categorized
(percentage) according to staining pattern for HLA-DR
and CEA
Heterogeneous
Heterogeneous expression of Homogeneous
Tumour expression of one ofthe expression of
stage both markers markers both markers
Dukes' stages
A and B 46% 41% 14%
(n=22)
Dukes' stages
C and D 9% 36% 55%
(n=11)
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Figure 1 Well-differentiated near diploid (ND) large bowel carcinoma (patient no. 4). (a) Routine staining
shows tubulo-villous structures with moderate atypia. (b) DNA prof'ile is clearly ND. Diploid lymphocyte
(LY) control indicated by arrow. (c) HLA-DR expression is patchy, varying from negative (bottom) to
intensely positive (top). (d) CEA staining in same field is more homogeneous and confined to an apical rim.
(a) x200, (c) and (d) x 135.
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Figure 2 Moderately-differentiated distinctly aneuploid (AN) large bowel carcinoma (patient no. 8). (a)
Routine staining shows glandular structures with severe atypia. (b) DNA profile shows distinct AN peak in
addition to a near diploid one. Diploid lymphocyte (LY) control indicated by arrow. (c) HLA-DR expression
is positive only in scattered clusters of' epithelial cells. Note numerous HLA-DR+ elements in stroma. (d)
CEA staining in same field shows uniform apical rim with cytoplasmatic extensions. Glandular content is also
positive. (a) x 200, (c) and (d) x 135. CAf :94-10.8
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Figure 3 Poorly-differentiated distinctly aneuploid (AN) large bowel carcinoma (patient no. 30). (a) Routine
staining shows the transition from adjacent colonic crypts (left) to anaplastic tumour elements (right). (b)
DNA profile shows distinct AN peak in addition to a near diploid one. Diploid lymphocyte (LY) control
indicated by arrow. (c) HLA-DR antigens are lacking within the tumour, with the exception of a few positive
macrophages: the adjacent transitional crypt epithelium expresses HLA-DR determinants. Note numerous
positive elements in the connective tissue. (d) CEA staining in same field is throughout the tumour, and
adjacent crypts are moderately positive. (a) x 200, (c) and (d) x 135.
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Figure 4 Poorly-differentiated large bowel carcinoma (patient no. 31). (a) Routine staining. (b) HLA-DR
expression is uniform and intense throughout the tumour. Note numerous positive elements in the stroma. (a)
and (b) x 135.
Conversely, 55% of the disseminated tumours
(Dukes' stages C and D) showed homogenous
expression for both HLA-DR and CEA and 91%
showed homogenous expression of at least one of
the two markers (Table II).
Non-neoplastic tissue elements
The crypt epithelium in the transitional mucosa
immediately adjacent to the tumours was always
positive for both HLA-DR and CEA; this was so
also in cases where the tumour epithelium was
negative, regardless of grade of tumour
differentiation. The fluorescence staining scores
obtained in this zone (data not presented) showed
no apparent relation to any of the variables
investigated. Normal colonic epithelium was
virtually unstained.
The endothelium of vessels in the tumour stroma
was often stained for HLA-DR antigen. In
addition, there was a large number of stained
histiocytes located around the epithelial elements; a
few such cells scattered within the tumours likewise
seemed to represent HLA-DR+ macrophages
(Figures 2 and 3).
Discussion
More than 90% of the large bowel carcinomas
included in our study were positive for HLA-DR
antigen--70% showing a patchy staining pattern.
Daar et al. (1982) described patchy expression of
HLA-DR in 8/15 colorectal carcinomas, the
remainders being negative. The positive patches
were reported to amount to 10-15% of the
examined tumour area and no correlation was
found with the degree of tumour differentiation.
The discrepant results might be due to different
antibody specificity and test sensitivity. We used a
3-step immunofluorescence technique applied to
ethanol-fixed sections. The primary murine
monoclonal antibody was directed against a non-
polymorphic determinant and produced the same
staining pattern in small intestinal epithelium as
that obtained previously in our laboratory by the550 T.O. ROGNUM et al.
use of a polyclonal rabbit antiserum to human
HLA-DR antigen (Scott et al., 1980). Daar et al.
(1982) used frozen sections and another monoclonal
antibody in a peroxidase- anti-peroxidase
technique. Thompson et al. (1982) found positive
staining in 7/9 colon carcinomas by means of
immunoperoxidase staining on frozen sections.
They claimed that metastatic tumours were
consistently HLA-DR + and showed a more
widespread staining reaction than localized
tumours. However, the small number of carcinomas
examined might explain the failure to find negative
metastatic tumours. The strikingly discrepant
finding of Natali et al. (1981) indicating that
undifferentiated tumours were consistently HLA-
DR- might likewise be ascribed to inclusion of a
few cases and perhaps differences in staining
sensitivity.
In our study we found a remarkable relation
between histological grade and the staining pattern
for epithelial HLA-DR: homogenously well-
differentiated tumours showed the greatest intra-
tumour variability, moderately-differentiated
tumours usually (80%) revealed one predominant
staining pattern; whereas the poorly-differentiated
ones were quite homogenously stained. A similar
but less distinct trend was seen for CEA expression.
When the staining patterns of the 2 epithelial
markers were considered together, a homogenous
expression of one or both antigens was clearly
associated with increasing aggressiveness in terms of
tumour dissemination (Table II).
These observations are in agreement with the
concept of clonal evolution of tumour cell
populations proposed by Nowell (1976). According
to this hypothesis tumour progression is due to an
acquired genetic lability permitting stepwise
selection of variant sublines of neoplastic cells. The
first malignant cell may build up early solid
tumours by giving rise to several clones with
different genotypic and phenotypic properties. Over
time most variants will die but one clone may
possess selective advantages and thereby emerge as
a predominant subpopulation.
Most of the well-differentiated tumours had a
ND DNA profile. One may postulate, therefore,
that carcinomas of this category usually contain a
variety of cell lines with approximately the same
DNA content but with different biological
properties including variable HLA-DR expression.
The DNA data further indicated that in the
development of tumours with a high malignant
potential, distinctly AN clones of poor
differentiation may arise and become increasingly
dominant. such emergence of monoclonality could
explain the remarkably homogeneous HLA-DR
staining-either negative or positive-shown by the
group of poorly-differentiated tumours. Neverthe-
less, disseminated tumours were sometimes ND (e.g.,
No. 24 in Table I) although preliminary clinical
follow-ups have indicated that they give rise to a
more protracted clinical course than the AN counter-
parts (Wolley et al., 1982; Rognum et al., 1983).
Our tentative conclusion is that well-
differentiated tumours with a low malignant
potential are heterogeneous with regard to HLA-
DR expression and tend to be ND, wheras clonal
selection taking place in highly malignant tumours
may favour homogeneous expression of HLA-DR
and CEA. Selection of particularly aggressive clones
is usually associated with a distinctly AN DNA
profile.
Although an AN DNA profile seems to be an
unfavourable prognostic feature (Wolley et al.,
1982; Rognum et al., 1983), the significance of the
various patterns of HLA-DR and CEA expression
remains unclear in terms of patient survival. We
have previously shown that CEA tends to produce
the strongest staining in moderately-differentiated
large bowel carcinomas (Rognum et al., 1982a).
The fact that highly malignant large bowel
carcinomas were associated with relatively low age
is in accordance with previous survival studies
(Becio & Bussey, 1965), but the age-dependent
endogeneous factors favoring tumour aggressiveness
are unknown.
We found abundant staining for HLA-DR
antigen in the crypt epithelium of the transitional
mucosa adjacent to the tumours. This epithelium is
probably subjected to stimulae from the carcinoma
and may express HLA-DR as a reactive sign like
activated T-cells (Hammerling, 1976) and macro-
phages (Steinman et al., 1980). In graft-versus-host
disease, colonic epithelium of the rat likewise
expresses such antigens (Mason et al., 1981). In
accordance with Scott et al. (1980) and Thompson
et al. (1982) we found that normal colonic
epithelium was virtually negative or only faintly
stained with the monoclonal antibody to HLA-DR
antigens used in this study.HLA-DR, CEA, AND DNA PLOIDY IN LARGE BOWEL CARCINOMA 551
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